The stability of the amorphous form of cefuroxime axetil in solid state

被引:11
|
作者
Jelinska, A
Dudzinska, I
Zajac, M
Oszczpowicz, I
机构
[1] Univ Med Sci, Dept Pharmaceut Sci, Fac Pharm, PL-60780 Poznan, Poland
[2] GlaxoSmithKline Pharmaceut SA, PL-60322 Poznan, Poland
[3] Inst Biotechnol & Antibiot, Dept Modified Antibiot, PL-02515 Warsaw, Poland
关键词
cefuroxime axetil-amorphous form; stability in the solid state;
D O I
10.1016/j.jpba.2006.02.008
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
The stability of the amorphous form of cefuroxime axetil was studied by means of the stress stability test. The degradation was evaluated using the HPLC method with UV detection (278 nm), as described in the monograph of Cefuroxime Axetil in European Pharmacopoeia. Liquid chromatography was performed with a H5 SAS Hypersil column (5 mu m particle size, 250 mu m x 4 turn), the mobile phase consisted of a mixture of 38 volumes of methanol and 62 volumes of a 23 g l(-1) solution of ammonium dihydrogen phosphate, a flow rate of 1.2 ml min(-1), and the internal standard was a solution of acetanilide in a mixture (1:1) of acetonitrile and water at a concentration of 0.2 mg ml(-1). At an increased temperature at RH = 0%, the degradation of cefuroxime axetil (CFA) diastereoisomers is the reversible first-order reaction, while that occurring in humid air (RH > 25%) is the reversible first-order autocatalytic reaction with Delta(3)-isomers and E-isomers of cefuroxime axetil and cefuroxime as the main products. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:1075 / 1081
页数:7
相关论文
共 50 条
  • [1] Evaluation of stability of cefuroxime axetil in solid state
    Zajac, M
    Jelinska, A
    Dobrowolski, L
    Oszczapowicz, I
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2003, 32 (06) : 1181 - 1187
  • [2] STABILITY OF CEFUROXIME AXETIL IN BEVERAGES
    STCLAIRE, RL
    CAUDILL, WL
    AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1989, 46 (02): : 256 - 256
  • [3] STABILITY OF CEFUROXIME AXETIL IN SUSPENSIONS
    PRAMAR, Y
    DASGUPTA, V
    BETHEA, C
    ZERAI, T
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 1991, 16 (05) : 341 - 344
  • [4] Cefuroxime axetil solid dispersion with polyglycolized glycerides for improved stability and bioavailability
    Dhumal, Ravindra S.
    Biradar, Shailesh V.
    Aher, Suyog
    Paradkar, Anant R.
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2009, 61 (06) : 743 - 751
  • [5] STABILITY OF CEFUROXIME AXETIL IN APPLE JUICE
    STCLAIRE, RL
    WILBOURNE, DK
    CAUDILL, WL
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1988, 7 (10) : 744 - 744
  • [6] CEFUROXIME AXETIL
    DELLAMONICA, P
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 1994, 4 (01) : 23 - 36
  • [7] CEFUROXIME AXETIL
    MARX, MA
    FANT, WK
    DRUG INTELLIGENCE & CLINICAL PHARMACY, 1988, 22 (09): : 651 - 658
  • [8] CEFUROXIME AXETIL
    EMMERSON, AM
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1988, 22 (02) : 101 - 104
  • [9] Preparation of amorphous cefuroxime axetil nanoparticles by sonoprecipitation for enhancement of bioavailability
    Dhumal, Ravindra S.
    Biradar, Shailesh V.
    Yamamura, Shigeo
    Paradkar, Anant R.
    York, Peter
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2008, 70 (01) : 109 - 115
  • [10] Determination of traces of amorphous cefuroxime axetil content in cefuroxime axetil crystalline drug substance using modulated differential scanning calorimetry (MDSC)
    Gunaseelan, S.
    Rao, Raghavendira
    Manimaran, A.
    Ramu, E.
    Sivakumar, B.
    Journal of Chemical and Pharmaceutical Research, 2012, 4 (11) : 4743 - 4751